- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06078748
The Lifestyle Exercise and Diet Trial (LEAD) 2.0
April 2, 2025 updated by: Laura Middleton, University of Waterloo
The Lifestyle, Exercise, and Diet Trial: A Virtual, Lifestyle Approach to Improve Cognition
The objective of this study is to investigate the feasibility of a virtually-delivered 6-month exercise and nutrition intervention in older adults with executive subjective cognitive decline (SCD).
Feasibility will be determined by recruitment, retention, and adherence rates.
Preliminary changes in cognition, physical function, and quality of life will be assessed as secondary outcomes.
The study will recruit 140 participants aged 65 to 80 who report they feel that their memory or other thinking abilities are declining.
Participants will be randomized into one of four study arms receiving different combinations of healthy lifestyle interventions.
Assessments will be conducted virtually at baseline, post-intervention (6 months), and follow-up (12 months).
All intervention sessions and assessment visits will be conducted online using the Zoom Healthcare platform and participants will log on using their own devices from home.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Detailed Description
The study will be a randomized control trial examining the feasibility of a 6-month virtually delivered exercise and nutrition intervention in older adults with executive SCD.
The study aims to recruit 140 participants.
After initial contact with potential participants, 2 screening visits (up to 45 minutes each) will be conducted to assess eligibility and obtain consent to participate in the study.
At the start of the program, after completing the program (6 months), and at follow-up (12 months), assessors will conduct 2 assessments (30-65 min each) using Zoom video conferencing to measure thinking abilities, physical function, and quality of life.
Participants will be randomized into one of four 6-month intervention arms (35 individuals per group x 4 groups): 1) EX + DIET: aerobic and resistance exercise (EX) with healthy diet counseling (DIET), 2) EX + ED: aerobic and resistance exercise (EX) with education on healthy lifestyle related to brain health (ED), 3) STRETCH + DIET: stretching and toning exercises (STRETCH) with healthy diet counseling (DIET), 4) STRETCH + ED: stretching and toning exercises (STRETCH) with education on healthy lifestyle related to brain health (ED).
All groups that receive EX and/or DIET will also receive the "Adult Strategies Put Into Real World Environments" (ASPIRE) goal strategy training, with goals focused on exercise and/or diet in order to overcome barriers and increase maintenance of lifestyle changes.
All intervention sessions and assessment visits will be conducted online using the Zoom Healthcare platform, and participants will log on using their own devices from home.
Study Type
Interventional
Enrollment (Estimated)
140
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ontario
-
Waterloo, Ontario, Canada, 41080
- University of Waterloo
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- 65-80 years old
Meet criteria for executive SCD
Answer Yes to both following questions:
- Do you feel like your memory or thinking is becoming worse?
- Does this worry you?
- ≥1SD above age and sex-based means on any of the sub scales of the Comprehensive Executive Function Inventory (CEFI) - Adult Version, indicative of concerns about executive function.
No objective cognitive impairment as indicated by:
- A global Clinical Dementia Rating (CDR) of ≤ 0.5
- A Blind Montreal Cognitive Assessment (MoCA) total score of >17
- Able to communicate in English
- Residents of Quebec, Ontario, Manitoba, and Saskatchewan to facilitate concurrent intervention delivery
- Low physical activity levels (<75min/week of moderate/vigorous physical activity on the Get Active Questionnaire)
- Screened safe to participate in moderate exercise using the Get Active Questionnaire or physician approval to engage in moderate intensity exercise without in-person supervision
- Poor diet quality (below Canadian older adults' median intake of fruits, vegetables, nuts and fish, reported using our Diet Screening Questionnaire)
- Able to participate remotely (i.e., availability of, or ability/willingness to adopt, a computer or tablet alongside high speed internet/data networks)
Exclusion Criteria:
- Dementia, stroke, or other chronic brain disease
- Chemotherapy or radiation to the head/neck in the past year
- Sensory impairments that would impede participation in the intervention or assessments
- Major psychiatric disorder
- Ongoing alcohol or drug abuse that in the opinion of the investigator may interfere with the subject's ability to comply with the study procedures.
- Contraindications for exercise as determined by the American College of Sports Medicine criteria
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: EX + DIET
Participants will engage in 3 sessions per week (2 EX, 1 DIET, totaling 4 hours per week), consisting of two virtual group sessions (totaling 3 hours) and one independent session (1 hour) (Table 1).
Virtual group sessions will occur in groups of 6-8 participants using the Zoom Healthcare platform (on a computer or tablet).
|
EX involves 2.5hrs of moderate intensity aerobic and resistance exercise per week.
EX will be instructed by a clinical exercise physiologist (CEP) or registered kinesiologist (RKIN).
The EX session will include a 5min warm-up, 20-30min of moderate intensity aerobic exercise, 20-30min of moderate intensity resistance training, and a 5min cool down.
The virtual video session will be pre-recorded, have similar composition, and will be led by the same instructor as the group sessions.
This group will also receive the "Adult Strategies Put Into Real World Environments" (ASPIRE) goal strategy training, with goals focused on exercise in order to overcome barriers and increase maintenance of lifestyle changes.
Other Names:
DIET involves one session per week of diet education delivered by a Registered Dietitian.
The DIET session will be 90 minutes during months 1-4, and 30 minutes in months 5 and 6.
DIET was developed by our team, emphasizing foods identified as supporting executive function, memory, and other cognitive abilities.
This group will also receive the "Adult Strategies Put Into Real World Environments" (ASPIRE) goal strategy training, with goals focused on diet in order to overcome barriers and increase maintenance of lifestyle changes.
Other Names:
|
|
Active Comparator: EX + ED
Participants will engage in 3 sessions per week (2 EX, 1 ED, totaling 4 hours per week), consisting of two virtual group sessions (totaling 3 hours) and one independent session (1 hour) (Table 1).
Virtual group sessions will occur in groups of 6-8 participants using the Zoom Healthcare platform (on a computer or tablet).
|
EX involves 2.5hrs of moderate intensity aerobic and resistance exercise per week.
EX will be instructed by a clinical exercise physiologist (CEP) or registered kinesiologist (RKIN).
The EX session will include a 5min warm-up, 20-30min of moderate intensity aerobic exercise, 20-30min of moderate intensity resistance training, and a 5min cool down.
The virtual video session will be pre-recorded, have similar composition, and will be led by the same instructor as the group sessions.
This group will also receive the "Adult Strategies Put Into Real World Environments" (ASPIRE) goal strategy training, with goals focused on exercise in order to overcome barriers and increase maintenance of lifestyle changes.
Other Names:
ED sessions designed to be of equal intensity and social engagement to the DIET intervention.
Participants will engage in group discussion and receive information on the brain and cognitive processes, the effect of age on cognition, and tips to promote healthy aging.
This will include lectures, watching documentaries and participating in various games.
Other Names:
|
|
Active Comparator: STRETCH + DIET
Participants will engage in 3 sessions per week (2 STRETCH, 1 DIET, totaling 4 hours per week), consisting of two virtual group sessions (totaling 3 hours) and one independent session (1 hour) (Table 1).
Virtual group sessions will occur in groups of 6-8 participants using the Zoom Healthcare platform (on a computer or tablet).
|
DIET involves one session per week of diet education delivered by a Registered Dietitian.
The DIET session will be 90 minutes during months 1-4, and 30 minutes in months 5 and 6.
DIET was developed by our team, emphasizing foods identified as supporting executive function, memory, and other cognitive abilities.
This group will also receive the "Adult Strategies Put Into Real World Environments" (ASPIRE) goal strategy training, with goals focused on diet in order to overcome barriers and increase maintenance of lifestyle changes.
Other Names:
STRETCH sessions will be time/frequency-matched to EX sessions (2.5hrs/week: 1.5hr in virtual group sessions; 1hr virtual video session) to control for social aspects and placebo effects of EX.Each STRETCH session will include a 5min warm-up, 5min of balance exercises, and 50min of stretching.
Difficulty will not be progressed.
STRETCH sessions will also be led by a CEP/RKIN instructor and video sessions will be pre-recorded by the same instructor.
Other Names:
|
|
Placebo Comparator: STRETCH + ED
Participants will engage in 3 sessions per week (2 STRETCH, 1 ED) totaling 4 hours per week), consisting of two virtual group sessions (totaling 3 hours) and one independent session (1 hour) (Table 1).
Virtual group sessions will occur in groups of 6-8 participants using the Zoom Healthcare platform (on a computer or tablet)
|
ED sessions designed to be of equal intensity and social engagement to the DIET intervention.
Participants will engage in group discussion and receive information on the brain and cognitive processes, the effect of age on cognition, and tips to promote healthy aging.
This will include lectures, watching documentaries and participating in various games.
Other Names:
STRETCH sessions will be time/frequency-matched to EX sessions (2.5hrs/week: 1.5hr in virtual group sessions; 1hr virtual video session) to control for social aspects and placebo effects of EX.Each STRETCH session will include a 5min warm-up, 5min of balance exercises, and 50min of stretching.
Difficulty will not be progressed.
STRETCH sessions will also be led by a CEP/RKIN instructor and video sessions will be pre-recorded by the same instructor.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Feasibility: Recruitment
Time Frame: 6 months
|
Recruitment rate per month
|
6 months
|
|
Feasibility: Adherence
Time Frame: 6 months
|
Percent of study intervention sessions attended by type
|
6 months
|
|
Feasibility: Retention
Time Frame: 6 months
|
Percent of consented participants who complete the post-intervention assessment of executive function
|
6 months
|
|
Feasiliby: Adherence (diet)
Time Frame: 6 months
|
Change in diet quality as assessed with the Eating Pattern Self-Assessment (minimum score 0, maximum score 15; higher scores indicate better diet quality)
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Retention by gender
Time Frame: 6 months
|
Does retention vary by gender (men, women, other)
|
6 months
|
|
Adherence by gender
Time Frame: 6 months
|
Does adherence vary by gender (men, women, other)
|
6 months
|
|
Executive Function
Time Frame: 6 months
|
the primary outcome of a future, large scale trial: an executive function composite derived from Cambridge Brain Sciences on-line assessments, where calculated effect size, variance, and co-variance will inform the sample size for the future, definitive RCT.
|
6 months
|
|
Memory
Time Frame: 6 months
|
a secondary outcome of a future, large scale trial: memory (Rey Auditory verbal Learning Test [RAVLT] immediate and delayed recall)
|
6 months
|
|
Physical Function
Time Frame: 6 months
|
a secondary outcome of a future, large scale trial: physical function (assessed using a 5 times sit-to-stand test)
|
6 months
|
|
Waist Circumference
Time Frame: 6 months
|
a secondary outcome of a future, large scale trial: waist circumference
|
6 months
|
|
Maintenance of change in executive function
Time Frame: 12 months
|
Differences in executive function betwen 6 and 12 months (6 months post-intervention) in an executive function composite derived from Cambridge Brain Sciences on-line assessments
|
12 months
|
|
Effect modification of executive function by sex
Time Frame: 6 months
|
To examine differences in observed effect sizes of executive function (as measured by an executive function composite derived from Cambridge Brain Sciences on-line assessments) vary by sex (male/female)
|
6 months
|
|
Effect modification of executive function by gender
Time Frame: 6 months
|
To examine differences in observed effect sizes of executive function (as measured by an executive function composite derived from Cambridge Brain Sciences on-line assessments) vary by gender (men, women, other)
|
6 months
|
|
Diet
Time Frame: 6 months
|
a secondary outcome of a future, large scale trial: diet quality (adherence to the study diet assessed by a study-specific questionnaire [Eating Patterns Self Assessment questionnaire: minimum score 0, maximum score 15; higher scores indicate better diet quality])
|
6 months
|
|
Physical Activity
Time Frame: 6 months
|
a secondary outcome of a future, large scale trial: physical activity (Physical Activity Scale for the Elderly [PASE], higher scores indicated more physical activity)
|
6 months
|
|
Health-related quality of life
Time Frame: 6 months
|
a secondary outcome of a future, large scale trial: Health-related Quality of Life assessed using the SF-36; minimum score 0, maximum score 100, higher scores indicate better quality of life)
|
6 months
|
|
Maintenance of diet quality
Time Frame: 12 months
|
Differences in diet quality (as measured by the Eating Patterns Self-Assessment questionnaire: minimum score 0, maximum score 15; higher scores indicate better diet quality) between 6 and 12 months (6 months post-intervention)
|
12 months
|
|
Maintenance of physical activity
Time Frame: 12 months
|
Differences in physical activity (as measured by the Physical Activity Scale for the Elderly, higher scores indicate greater physical activity) between 6 and 12 months (6 months post-intervention)
|
12 months
|
|
Effect modification of physical activity by sex
Time Frame: 12 months
|
To examine differences in observed effect for physical activity (as measured by the Physical Activity Scale for the Elderly, higher scores indicate more physical activity) vary by sex (male/female)
|
12 months
|
|
Effect modification of physical activity by gender
Time Frame: 12 months
|
To examine differences in observed effect for physical activity (as measured by the Physical Activity Scale for the Elderly, higher scores indicate more physical activity) vary by gender (men, women, other)
|
12 months
|
|
Effective modification of diet quality by sex
Time Frame: 12 months
|
To examine differences in observed effect sizes for diet quality (measured by Eating Patterns Self-Assessment questionnaire; minimum score 0, maximum score 15, higher scores indicate better diet quality) by sex (male/female)
|
12 months
|
|
Effective modification of diet quality by gender
Time Frame: 12 months
|
To examine differences in observed effect sizes for diet quality (measured by Eating Patterns Self-Assessment questionnaire; minimum score 0, maximum score 15, higher scores indicate better diet quality) by gender (men, women, other)
|
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Laura Middleton, PhD, University of Waterloo
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 3, 2023
Primary Completion (Estimated)
December 1, 2025
Study Completion (Estimated)
December 1, 2025
Study Registration Dates
First Submitted
June 1, 2023
First Submitted That Met QC Criteria
October 3, 2023
First Posted (Actual)
October 12, 2023
Study Record Updates
Last Update Posted (Actual)
April 4, 2025
Last Update Submitted That Met QC Criteria
April 2, 2025
Last Verified
April 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 44616
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
IDP will be uploaded to an open access data repository.
The exact repository has yet to be decided.
All data will be de-identified.
IPD Sharing Time Frame
Study protocol, analysis plan, and consent forms will become available shortly after ethics approval.
Clinical study reports will become available after the last data collection and analysis in December 2025. The data will remain on the repository indefinitely.
IPD Sharing Access Criteria
Open access
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Subjective Cognitive Decline
-
China Medical University HospitalNot yet recruitingSubjective Cognitive Decline | Subjective Cognitive Decline (SCD)Taiwan
-
IRCCS Policlinico S. DonatoAzienda Ospedaliero-Universitaria CareggiRecruitingSubjective Cognitive Impairment | Subjective Memory Decline | Subjective Cognitive Decline (SCD) | Subjective Memory Complaint | Subjective Cognitive Concerns | Subjective Cognitive Complaints (SCCs)Italy
-
BaycrestNot yet recruitingSubjective Cognitive Impairment | Subjective Cognitive Decline (SCD)Canada
-
Hebrew University of JerusalemMinistry of Health, IsraelRecruitingSubjective Cognitive Impairment | Subjective Cognitive Decline (SCD) | Subjective Memory ComplaintsIsrael
-
Beijing Hospital of Traditional Chinese MedicineUnknownSubjective Cognitive Decline | Subjective Cognitive ComplaintChina
-
University of FloridaNot yet recruitingHealthy Subjects | Subjective Cognitive Decline (SCD)United States
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...Active, not recruitingSubjective Cognitive Decline (SCD) | Depression DisorderChina
-
The Hong Kong Polytechnic UniversityRecruitingSubjective Cognitive DeclineChina
-
University Hospital TuebingenNot yet recruitingSubjective Cognitive DeclineGermany
-
Vanderbilt University Medical CenterRecruiting
Clinical Trials on EX
-
University of Colorado, DenverCompletedOverweight and ObesityUnited States
-
University Hospital, Clermont-FerrandLaboratoire des Adaptations Métaboliques à l'Exercice en conditions Physiologiques...Completed
-
Medtronic EndovascularWithdrawnPeripheral Arterial Disease
-
MediWound LtdRecruitingNodular Basal Cell Carcinoma | Superficial Basal Cell CarcinomaUnited States
-
St. Antonius Hospital GronauCompleted
-
Neuromed IRCCSRecruitingDrug Resistant EpilepsyItaly
-
New York State Psychiatric InstituteNational Institute of Mental Health (NIMH)CompletedObsessive-Compulsive DisorderUnited States
-
University Health Network, TorontoRecruitingChemotherapy-induced Peripheral Neuropathy (CIPN)Canada
-
Emory UniversityNational Institute on Aging (NIA)Recruiting